• Guideline Summary
  • NGC:009239
  • 1999 (revised 2012)

ACR Appropriateness Criteria® orbits, vision and visual loss.

  • Guideline Summary
  • NGC:010771
  • 2015 Jul

Aflibercept for treating diabetic macular oedema.